血清学阴性类风湿关节炎关节液中抗环瓜氨酸肽抗体、抗突变型瓜氨酸波形蛋白抗体的测定及临床意义

doi:10.3969/j.issn.1671-167X.2016.06.002

摘要/Abstract

摘要：

目的：检测血清学阴性类风湿关节炎(serum negative rheumatoid arthritis,SNRA)患者的关节液中抗环瓜氨酸肽（cyclic citrullinated peptide,CCP）抗体、抗突变型瓜氨酸波形蛋白（mutated citrullinated vimentin, MCV）抗体水平，了解关节液中这两种抗体对诊断SNRA的临床意义。方法: 应用酶联免疫吸附测定（enzyme linked immunosorbent assay, ELISA）法检测两组患者膝关节液中抗CCP抗体和抗MCV抗体，实验组为SNRA患者，共29例，对照组为骨关节炎（osteoarthritis,OA）患者，共28例，并收集两组患者的临床表现及实验室指标。结果: 实验组29例SNRA患者膝关节液中抗CCP抗体阳性者10例（34.5%），测定值为（114.5±62.6） U/mL；抗MCV抗体阳性者6例（20.7%），测定值为（32.0±11.3） U/mL；对照组28例OA患者膝关节液中3例抗CCP抗体阳性（10.7%），测定值为（20.6±0.1） U/mL，2例抗MCV抗体阳性（7.1%），测定值为（22.1±1.7） U/mL。SNRA组关节液抗CCP抗体的阳性率显著高于对照组（34.5% vs.10.7%， χ2=4.571, P＜0.05）；SNRA组关节液抗MCV抗体的阳性率高于对照组（20.7% vs.7.1%， χ2=2.167, P＞0.05），但差异无统计学意义；抗CCP抗体在SNRA中的敏感性为34.5%，特异性为89.3%，阳性预测值为76.9%，阴性预测值为56.8%；抗MCV抗体敏感性为20.7%，特异性为92.9%，阳性预测值为75.0%，阴性预测值为53.1%；膝关节液中抗CCP抗体和抗MCV抗体两者联合检测的敏感性为48.0%，特异性为82.8%，SNRA关节液抗CCP抗体阳性组、抗MCV抗体阳性组与各自阴性组相比较，在年龄、病程和晨僵方面差异均无统计学意义，而膝关节液抗CCP抗体阳性组和抗MCV抗体阳性组红细胞沉降率（erythrocyte sedimentation rate, ESR）、C反应蛋白（C-reactive protein，CRP）和28个关节的疾病活动评分（the disease activity score in 28 joints，DAS28）均比各自阴性组高(P均<0.01)。抗CCP抗体与ESR和CRP之间呈正相关(r=0.567, P<0.01; r=0.664, P<0.01)；抗MCV抗体与ESR和CRP之间呈正相关(r=0.344, P<0.01; r=0.749, P<0.01) 。结论: SNRA关节液抗CCP抗体和抗MCV抗体联合检测有助于SNRA诊断和疾病活动的判断。

关键词: 关节炎, 类风湿, 血清, 类风湿因子, 抗体, 抗环瓜氨酸肽, 抗体, 抗突变型瓜氨酸波形蛋白, 滑液

Abstract:

Objective： To explore the significance of synovial fluid（SF）anti-cyclic citrullinated peptide (CCP) antibodies and anti-mutated citrullinated vimentin (MCV) antibodies in the diagnosis of serum negative rheumatoid arthritis (SNRA). Methods: Enzyme linked immunosorbent assay (ELISA) method was apllied in the detection of two groups of patients with knee joint fluid resistance against CCP antibody and antibody of MCV, the experimental group to SNRA patients, a total of 29 cases, and the control for patients with osteoarthritis (OA), a total of 28 cases, and clinical manifestations and laboratory parameters of the two groups were collected. Results: The positive rate of synovial fluid anti-CCP was 34.5% in the SNRA patients, which was significantly higher than 10.7% in the control patients（χ2=4.571, P＜0.05）. The positive rate of synovial fluid anti-MCV was 20.7% in the SNRA patients, which was significantly higher than 7.1% in the control patients（χ2=2.167, P＞0.05）. The SNRA patients of SF anti-CCP and anti-MCV positive had no significant difference from the SNRA patients of SF anti-CCP and anti-MCV negative in age, course and morning stiffness. The levels of erythrocyte sedimentation rate (ESR) , C-reactive protein(CRP) and DAS28 scores in the SF anti-CCP positive patients were higher than those of the SF anti-CCP negative patients. The levels of ESR, CRP and DAS28 scores in the SF anti-MCV positive patients were higher than those of the SF anti-MCV negative patients, (all P<0.01). SF anti-CCP had correlation with ESR, CRP(r=0.567, P<0.01; r=0.664, P<0.01). SF anti-MCV had correlation with ESR, CRP(r=0.344, P<0.01; r=0.749, P<0.01). Conclusion: SF anti-CCP and anti-MCV are helpful for the diagnosis of SNRA and judgement of SNRA activity.

中图分类号:

曲世晶，叶华，贾汝琳，栗占国. 血清学阴性类风湿关节炎关节液中抗环瓜氨酸肽抗体、抗突变型瓜氨酸波形蛋白抗体的测定及临床意义[J]. 北京大学学报(医学版), 2016, 48(6): 933-936.

QU Shi-jing, YE Hua, JIA Ru-lin, LI Zhan-guo. Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with #br# serum negative rheumatoid arthritis[J]. Journal of Peking University(Health Sciences), 2016, 48(6): 933-936.

参考文献

相关文章 15

[1]	肖云抒,朱冯赟智,罗澜,邢晓燕,李玉慧,张学武,沈丹华. 88例重叠肌炎的临床及免疫学特征[J]. 北京大学学报（医学版）, 2021, 53(6): 1088-1093.
[2]	宋志博,耿研,邓雪蓉,张晓慧,张卓莉. 肌肉骨骼超声在指导银屑病关节炎临床分型中的价值[J]. 北京大学学报（医学版）, 2021, 53(6): 1061-1066.
[3]	张璐,胡小红,陈澄,蔡月明,王庆文,赵金霞. 类风湿关节炎初治患者颈椎失稳情况及临床特征[J]. 北京大学学报（医学版）, 2021, 53(6): 1049-1054.
[4]	邓雪蓉,孙晓莹,张卓莉. 类风湿关节炎患者足踝部体征和超声下病变的一致性[J]. 北京大学学报（医学版）, 2021, 53(6): 1037-1042.
[5]	罗靓,霍文岗,张钦,李春. 类风湿关节炎合并角膜溃疡的临床特点和相关因素分析[J]. 北京大学学报（医学版）, 2021, 53(6): 1032-1036.
[6]	钟华,徐丽玲,白明欣,苏茵. 类风湿关节炎患者趋化因子CXCL9和CXCL10在骨侵蚀中的作用[J]. 北京大学学报（医学版）, 2021, 53(6): 1026-1031.
[7]	娄雪,廖莉,李兴珺,王楠,刘爽,崔若玫,徐健. 类风湿关节炎患者外周血TWEAK基因启动子区甲基化状态及其表达[J]. 北京大学学报（医学版）, 2021, 53(6): 1020-1025.
[8]	罗澜,邢晓燕,肖云抒,陈珂彦,朱冯赟智,张学武,李玉慧. 抗合成酶综合征合并心脏受累患者的临床及免疫学特征[J]. 北京大学学报（医学版）, 2021, 53(6): 1078-1082.
[9]	张朴丽,杨红霞,张立宁,葛勇鹏,彭清林,王国春,卢昕. 血清YKL-40在诊断抗黑色素瘤分化相关基因5阳性皮肌炎合并严重肺损伤中的价值[J]. 北京大学学报（医学版）, 2021, 53(6): 1055-1060.
[10]	伊文霞,魏翠洁,吴晔,包新华,熊晖,常杏芝. 长疗程利妥昔单抗治疗难治性幼年型特发性炎症性肌病3例[J]. 北京大学学报（医学版）, 2021, 53(6): 1191-1195.
[11]	李正芳,吴雪,武丽君,罗采南,石亚妹,钟岩,陈晓梅,孟新艳. Rhupus综合征的临床特点[J]. 北京大学学报（医学版）, 2021, 53(5): 933-937.
[12]	吴燕芳,高飞,林滇恬,陈志涵,林禾. 托法替布联合治疗抗MDA5抗体阳性的无肌病皮肌炎并发快速进展型间质性肺病5例临床分析[J]. 北京大学学报（医学版）, 2021, 53(5): 1012-1016.
[13]	王贵红,左婷,李然,左正才. 瑞巴派特在大鼠痛风性关节炎急性发作中的作用[J]. 北京大学学报（医学版）, 2021, 53(4): 716-720.
[14]	吴俊慧,陈泓伯,武轶群,吴瑶,王紫荆,吴涛,王梦莹,王斯悦,王小文,王伽婷,于欢,胡永华. 2015—2017年北京市2型糖尿病患者骨关节炎患病的相关因素[J]. 北京大学学报（医学版）, 2021, 53(3): 518-522.
[15]	赵凯,常志芳,王志华,庞春艳,王永福. 基因沉默肽基精氨酸脱亚胺酶4的表达对胶原诱导关节炎小鼠肺间质病变的影响[J]. 北京大学学报（医学版）, 2021, 53(2): 235-239.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed